Aug 27, 2020 / 12:00PM GMT
Unidentified Participant
Greetings from the Biostock studio here at medical village in Lund, we're pleased to invite you to this R & D market update event featuring Alligator Bioscience a Loon-based biotech company developing immune-oncology treatments. The program for today's event will begin with Alligator Biosciences' CEO, who will talk more about eight or 15 metas alimon. At 2:15, we will hear from the company, CEO Malin Carlsson who will discuss instead of 2017 and its development track.
Then at 2:30, we will be joined via Zoom by professor Ignacio Melero from the University of Nevada in Spain. He will talk about 4-1BB as an attractive target in immuno-oncology. At 2:45, the program will finish off with a Q&A session and conclude at three. So now I leave the words to Pat Nalon and Marlon Carlson. Welcome both.
Per Norlén - Alligator Bioscience AB - CEO
Thank you. So again, welcome. This is an R&D update, and we are today going to focus on our clinical programs on the actual drug candidates, the properties and how we're going to
Alligator Bioscience AB R&D Market Update Transcript
Aug 27, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers